DekaBank Deutsche Girozentrale Sells 10,633 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

DekaBank Deutsche Girozentrale decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 925,789 shares of the healthcare conglomerate's stock after selling 10,633 shares during the quarter. UnitedHealth Group makes up 0.9% of DekaBank Deutsche Girozentrale's portfolio, making the stock its 18th biggest position. DekaBank Deutsche Girozentrale owned approximately 0.10% of UnitedHealth Group worth $474,990,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. Kapitalo Investimentos Ltda purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $41,000. Finally, Copia Wealth Management bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $42,000. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. KeyCorp cut their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Barclays cut their price target on UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Baird R W lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research note on Friday, June 20th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $415.57.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 0.4%

NYSE:UNH traded up $1.06 during midday trading on Tuesday, hitting $304.77. The stock had a trading volume of 1,370,823 shares, compared to its average volume of 11,057,072. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a market capitalization of $276.47 billion, a price-to-earnings ratio of 12.76, a PEG ratio of 1.48 and a beta of 0.45. The stock has a 50-day moving average of $322.66 and a 200 day moving average of $445.65. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the business posted $6.91 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.90%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.